Newsroom
Joslin Diabetes Center Earns NCQA’s Highest Level of National Recognition for Quality Care
The NCQA rating was awarded for Joslin's responsiveness to patients and medical colleagues, cooperation and integration with other healthcare groups, and dedication to improvement. Joslin and AJMC will present "Patient-Centered Diabetes Care 2015" in Boston April 16-17, 2015.
Cancer Treatments the Next Big Area for Cost Saving Opportunities
Involving the pharmacy benefits manager earlier in the decision-making process could lead to cost savings on cancer treatments, Express Scripts Chief Executive Officer George Paz said at the J.P. Morgan Healthcare Conference in San Francisco, California.
Diagnostic Testing Guidelines for Lung Cancer to Be Revised
In addition to recommendations on alternate techniques, the revised guideline, being jointly developed by CAP, IASLC, and AMP, will also include testing for emerging biomarkers in lung cancer.
Express Scripts Wants Early Discussions to Help Lower Treatment Costs
After their decision to include Abbvie's triple combination for hepatitis C on their formulary, over Gilead's more expensive regimens, Express Scripts indicated at the J. P. Morgan Healthcare Conference that they'll continue the stance of choosing treatments that are equally effective but save costs, especially in cancer.
"Choose Wisely" in Rectal Cancer a Retrospective Study Indicates
The retrospective analysis of 145 patients with stage 2-3 rectal cancer found that the "wait and watch" approach, instead of surgery, in patients treated with chemotherapy might work just as well when measuring survival as an outcome.
Majority of Older Adults With Diabetes Likely Being Overtreated
Older adults with diabetes are being overtreated for their condition, leading to harmful outcomes such as hypoglycemia, according to a study published in JAMA Internal Medicine.
Pharma Giants to Collaborate on Immuno-oncology Regimens
Merck and Eli Lilly have entered an agreement to collaborate on clinical trials to evaluate the former's recently approved PD-1 inhibitor, Keytruda (pembrolizumab) in combination with Lilly's oncology agents in several clinical trials targeting multiple tumor types.
Supreme Court Rejects New Challenge to Obamacare Law
The US Supreme Court on Monday declined to take up another broad challenge to President Barack Obama's signature healthcare law, this time from the Association of American Physicians and Surgeons and the Alliance for Natural Health USA.
E-Prescribing Preferences, Perceptions Among Older Adults
Not only do a majority of older patients expect e-prescriptions, but 81% preferred e-prescriptions to paper in a study published in the Perspectives in Health Information Management.
Study Highlights Need to Reduce Global Teen Exposure to Second-hand Smoke
The study evaluated data collected through a global collaboration between research institutes in the United States, India, and Africa. Study results pointed to a high rate of exposure of non-smoking teenagers to second-hand smoke, both at home and outside.
Cancer Survivors Identify Lingering Medical, Financial Troubles
The number of cancer survivors may be on the rise, but they experience continuing issues that can impair their quality of life beyond 5 years of survival, according to a new study published in Cancer.
Pfizer Gains Access to 23andMe's Genetic Mine
23andMe is betting its growing troves of genetic data will prove essential to drug companies, medical researchers, and even health and wellness companies.
Supreme Court Battle Brewing Over Medicaid Fees
Providers and patient advocates nationwide are deeply worried about a US Supreme Court case that they say could restrict their ability across the country to seek judicial relief from low Medicaid reimbursement rates.
A New Target in Difficult-to-Treat Breast Cancer?
The pre-clinical study by researchers at the Wellcome Trust Sanger Institute in UK point to the gene BCL11A as a possible driver of this aggressive form of breast cancer.
A New Geriatric Care Model Limits Hospitalization Among Nursing Facility Residents
A new study reports on the first year of the implementation of OPTIMISTIC, an innovative program they developed and implemented to prevent unnecessary hospitalizations of nursing facility residents.
Nivolumab Phase 3 Trial in NSCLC Stopped Early; Superior OS
Mid-trial evaluation by an independent Data Monitoring Committee found overall survival with Opdivo (nivolumab) in the Checkmate-017 trial was significantly better than the control arm. BMS now plans to submit results to the FDA for approval of the PD-1 inhibitor in lung cancer.
NY Telehealth Bill Signed
New telehealth bill signed into law in New York will bring much-needed healthcare to rural and underserved communities and require Medicaid to reimburse telehealth service costs.
Will Twin Medi-Cal Cuts Affect Access?
The combination of 2 Medi-Cal primary care rate decreases could mean primary care providers who see a lot of Medi-Cal patients will have to scale back or stop seeing those beneficiaries.
Combination Therapy Eliminates HCV in Liver Transplant Patients
Interferon-free combination therapy in hepatitis C patients who undergo liver transplantation can eliminate the virus, according to 2 studies published in Gastroenterology.
Eliminating Federal Marketplace Subsidies Will Increase Costs Up to 47%
Studies from RAND and the Urban Institute estimate that eliminating subsidies for the federally facilitated Marketplaces would increase premiums between 35% and 47% and cause at least 8.2 million people to drop coverage.
Anthem Selects Gilead as Primary Supplier of Hepatitis C Drugs
Health insurer Anthem Inc has reached a deal under which Gilead Sciences Inc's hepatitis C drug Harvoni will be the primary treatment for patients infected with the most common strain of the liver-destroying virus.
Medical Clinics Take Over Malls' Empty Spaces
As retailers struggle to keep up with changing shopping trends, mall operators across the US are looking to fill spaces left empty by the likes of Sears and RadioShack. There is one promising new group of tenants: walk-in medical clinics.
For-Profit Hospitals Poised for Stronger 2015 Than Not-For-Profits
Cost cutting and new initiatives aimed at bringing in more patients will lead to another strong year in 2015 for for-profit hospitals. Meanwhile, their not-for-profit counterparts have been given negative outlooks by credit-rating agencies.
ASCO Backs the FDA on Regulating Lab-Based Diagnostics
In comments to the House Committee on Energy and Commerce, Health Subcommittee, ASCO strongly supported the FDA's resolution to rigorously regulate laboratory-developed tests.
Age Determines HPV Persistence in Men
The study, published in the journal Cancer Prevention Research found that HPV persisted for 12 months or more in men older than 45 years of age, which could increase their susceptibility to developing head and neck cancer.